Karappan thailam (internal) and nunapattai thailam(external) for karappan(Atopic dermatitis) for children

PHASE II NON RANDOMIZED CLINICAL STUDY ON BALAKARAPPAN (ATOPIC DERMATITIS) WITH THE EVALUATION OF SIDDHA TRIAL DRUG KARAPPAN ENNAI(INTERNAL) AND NUNAPATTAI THAILAM (EXTERNAL) IN CHILDREN

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/11/047404

Enrollment

Registered

2022-11-17

Start date

Unknown

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: Karappan ennai(Internal) Nunapattai thailam(External): Karappan ennai(internal)-5ml Od duration-21 days. Nunapattai thailam- External application,duration-21 days. Control Intervention1

Eligibility

Inclusion criteria

Inclusion criteria: Itching,erythema,papules,vesicles,oozing,crusting, scaling and lichenification

Exclusion criteria

Exclusion criteria: Psoriasis,scabies,photo dermatitis,ichthyosis vulgaris,pityriasis alba

Design outcomes

Primary

Measure	Time frame
Reduction in EASI score(Eczema area severity index) Reduction in clinical symptoms like itching,papules ,pustules ,oozing,scaling,lichenification Photos of the patient before and after treatment for the evidence of clinical improvementTimepoint: 21 Days	—

Secondary

Measure	Time frame
It is assessed by comparing the safety parameters before and after treatment.Timepoint: 21 days	—

Countries

India

Contacts

Public ContactDr M RAHUL

Government Siddha medical college arumbakkam

cspriya2004@gmail.com9445661808

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026